Optimizing the Radiological Selection and Transfer Model in Stroke Patients Presenting 6-24h After Onset (VESTA Study)
VESTA
Treatment of Stroke in the Extended Window: Optimization of the Radiological Selection and Transfer Model in Patients With a Stroke Presenting 6-24h After Symptoms Onset (VESTA Study)
1 other identifier
observational
2,173
1 country
1
Brief Summary
We aim to optimize the radiological selection and the transfer model in patients with a 6-24h stroke for a fairer and broader access to a reperfusion treatment. The specific objectives are:
- 1.To confirm that the selection of patients for reperfusion therapies in the late window is safe by applying the same clinical and imaging criteria recommended by clinical guidelines for the early window treatment selection.
- 2.To evaluate the performance of non-contrast CT by applying immediate post-processing software for the selection of patients for reperfusion treatment in the late window.
- 3.To analyze the prehospital and arrival variables at the primary stroke center to generate decision trees that optimize the transfer decision in patients with activation of the stroke code in \>6h from the onset of symptoms.
- 4.retrospective analysis with a detailed evaluation of the images of the included patients and generation of "machine learning" models that accurately predict the probability of receiving reperfusion treatment in the late window.
- 5.validation of the models in a prospective study. Clinical, radiological and transport variables will be studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2022
CompletedStudy Start
First participant enrolled
January 14, 2022
CompletedFirst Posted
Study publicly available on registry
March 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2023
CompletedAugust 22, 2023
August 1, 2023
1.6 years
January 13, 2022
August 18, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
mRS at 90 days
Percentage of patients with functional independence, defined as mRS \< or =2 on day 90 as assessed centrally by blinded evaluators of the Catalan Stroke Master Plan.
90 days after stroke
Rate of patients treated with mechanical thrombectomy
less than 24 hours after the diagnostic test
Secondary Outcomes (2)
Mortality at discharge and at day 90
90 days after stroke
Symptomatic intracerebral hemorrhage, defined as PH2 or SAH on imaging test at 24-72 hours associated with a worsening in NIHSS ≥ 4 points
From 24 to 72 hours after stroke
Study Arms (2)
Stroke patients 6-24h receiving non-contrast CT + CTA
Stroke patients 6-24h undergoing non-contrast CT + CTA to decide stroke therapy
Stroke patients 6-24h receiving multimodal imaging
Stroke patients 6-24h undergoing NCCT+CTA+CTP or MRI with DWI and PWI imaging to decide stroke therapy
Interventions
MR perfusion or multiparametric CT including NCCT, CTA and CTP
NCCT+CTA
Eligibility Criteria
Consecutive patients with stroke suspiction in Catalonia included in the CICAT registry
You may qualify if:
- Age older than 18 years,
- Diagnosis of acute cerebral infarction,
- More than six hours of evolution or uncertain chronology of symptoms,
- Absence of disability prior to stroke (modified Rankin score 0-2),
- NIHSS score\>5,
- Neuroimaging study including at least one non-contrast cranial CT scan within 60 minutes of arrival at the hospital center.
- SUBSTUDY 2. OPTIMIZATION OF CIRCUITS AND TRANSFER MODEL IN PATIENTS WITH STROKE IN THE EXTENDED WINDOW OF TREATMENT.
- Age over 18 years,
- Suspicion of acute cerebral infarction,
- More than six hours of evolution or uncertain chronology of symptoms,
- absence of pre-stroke disability (modified Rankin score 0-2),
- NIHSS score greater than 5.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Germans Trias i Pujol Hospitallead
- Carlos III Health Institutecollaborator
Study Sites (1)
Germans Trias i Pujol Hospital
Badalona, Barcelona, 08916, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
January 13, 2022
First Posted
March 28, 2022
Study Start
January 14, 2022
Primary Completion
August 15, 2023
Study Completion
August 15, 2023
Last Updated
August 22, 2023
Record last verified: 2023-08